Stanford School of Medicine

Meet the Stanford Medicine emergency physicians and nurses who helped safeguard athletes and officials during FIFA World Cup games at Levi’s Stadium.

Cellular and molecular interactions around tumors give insight into their structures and weaknesses, but measuring them has been expensive and slow. A Stanford Medicine AI platform flips the script.

Antibody therapies show limited success in solid tumors. A new Stanford Medicine imaging method, precise enough to locate antibodies at subcellular resolution, hints at why.

Family- and individual-based therapy both improve eating variety in children with the pediatric eating disorder ARFID.

How do the drugs work? What happens if you stop? Is it safe to take them long term? Clinicians share everything you need to know about GLP-1 agonists.

The renowned gastrointestinal radiologist and former director of diagnostic radiology at Stanford is remembered for his infectious enthusiasm and dedication to teaching.

An $18 million grant will fund a new approach to broad-based protection against respiratory threats, from flu and COVID-19 to bacteria and allergens.

Modulating a molecular seesaw could reduce inflammation, aid wound healing, and curb skin cancer growth.

A new drug is doubling survival times for one of the deadliest cancers. Stanford Medicine’s Daniel Delitto breaks down how it works and what else is on the horizon.

A study of 2.5 million California births finds women hospitalized for hyperemesis gravidarum face significantly elevated risks of preterm birth, anemia, and preeclampsia.